Actuate Therapeutics, Inc. Common stock Financial Flexibility Index
Actuate Therapeutics, Inc. Common stock financial flexibility index. Actuate Therapeutics, Inc. Common stock (ACTU) has a Financial Flexibility Index of -0.99x as of September 2025. Free cash flow of $-6.68 Million (operating CF $-6.68 Million minus capex $3.00) represents -1% of total liabilities ($6.78 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Actuate Therapeutics, Inc. Common stock (2022–2024)
Financial flexibility index of Actuate Therapeutics, Inc. Common stock from 2022 to 2024. Historical Financial Flexibility Index trend for Actuate Therapeutics, Inc. Common stock across 3 annual periods. Explore ACTU cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Actuate Therapeutics, Inc. Common stock Financial Flexibility Index by Year (2022–2024)
Actuate Therapeutics, Inc. Common stock financial flexibility index by year from 2022 to 2024. Year-by-year free cash flow to debt coverage for Actuate Therapeutics, Inc. Common stock. For the full cash flow conversion analysis, see Actuate Therapeutics, Inc. Common stock (ACTU) cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.37x | $-21.84 Million | $-21.84 Million | $9.21 Million | ▼ -1024.9% |
| 2023 | -0.21x | $-21.63 Million | $-21.63 Million | $102.62 Million | ▲ +93.3% |
| 2022 | -3.15x | $-17.79 Million | $-17.79 Million | $5.65 Million | — |